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1059-20 Does Elevating Catecholamine Concentrations Impact 
the Defibrillation Threshold?
James S. Kalus, Michael White, Danette Guertin, Michael F. Caron, Brian F. McBride, 
Jeffrey Kluger, Hartford Hospital, Hartford, CT, University of Connecticut, Storrs, CT
Background: The defibrillation threshold (DFT) is important for setting defibrillation
energy of implanted cardioverter-defibrillators (ICD). DFT is determined under anesthe-
sia, which lowers circulating catecholamines. Whether DFT is impacted by epinephrine
(EPI), an alpha-1, beta-1 and beta-2 receptor stimulator, and norepinephrine (NOREPI),
a beta- and alpha-1 receptor stimulator, is unknown. Also, concomitant beta-blockers
(BBLs) may alter DFT effects of catecholamines. Our objective was to determine the
impact of elevated EPI or NOREPI concentrations on DFT in ICD patients with and with-
out concomitant cardioselective BBLs. Methods: DFT testing was performed per a step-
down protocol. Once routine DFT was determined, patients (n = 50, 64.8 ± 13.1 yrs, 72%
male, 70% CAD, EF = 35.8 ± 15.5%) were stratified by use of cardioselective BBLs
(n=30) or no BBLs (n=20) and randomized to an intravenous infusion of EPI, NOREPI or
placebo (2mcg/min). After achieving steady state (7 min), the DFT was confirmed by
repeat testing (experimental DFT). Results: NOREPI reduced DFT in the BBL (p=0.037)
and no BBL (p=0.076) groups. The direction of EPI's effect on DFT depended on use of
concomitant BBLs. In the EPI group, those on BBLs experienced a negative DFT change
from baseline and DFT change in those not on BBLs was positive (-1.5 ± 2.4 vs. +2.0 ±
4.6, p=0.029). DFT was unchanged with placebo. Conclusion: NOREPI decreases DFT,
possibly by alpha stimulation, and the effect of EPI on DFT differs depending on BBL use.
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1059-21 Skeletal Myoblast Transplantation Through a Catheter-
Based Coronary Sinus Approach: An Effective Means of 
Improving Function of Infarcted Myocardium
Camille Brasselet, Claire Carrion, Miguel Morichetti, Emmanuel Messas, Patrick 
Bruneval, Jean-Thomas Vilquin, Antoine Lafont, Albert A Hagège, Philippe Menasché, 
Michel Desnos, Hôpital Européen Georges Pompidou, Paris, France, Ecole de Chirurgie 
de l'Assistance Publique-Hôpitaux de Paris, Paris, France
Whereas the feasibility of percutaneous techniques of cell delivery has been established,
evidence for their functional efficacy still remains scarce. Because the transvenous
approach is relatively simple, we first undertook an histological study which showed the
ability of this route to achieve a successful engraftment of skeletal myoblasts into target
scars. The present experiments were designed to assess the functional relevance of
these findings. An anterior myocardial infarction was induced in 12 sheep by the release
of a thrombogenic coil in the left anterior descending coronary artery. Simultaneously, a
muscle biopsy was harvested and expanded. Two weeks later, left ventricular (LV) func-
tion was assessed by echocardiography and sheep were instrumented percutaneously
with a dedicated catheter (TransAccessTM, Transvascular, Menlo Park, CA) which incor-
porates a tipped phase-array ultrasound probe for guidance and an extendable needle for
puncture of the venous wall. A microcatheter is then advanced through the needle into
the infarcted tissue and used for cell delivery. Following the baseline echo, sheep were
randomly allocated to receive 4 staged in-scar injections of either autologous cells (200
to 250 x 106 in 8 mL, of which _ 80% were myoblasts identified by a positive staining for
CD 56, n = 6) or an equivalent volume of culture medium (n = 6). There were no acute
postinjections complications like pericardial blood effusion or arrhythmias. Two months
later, LV function was reassessed blindly and hearts were explanted for subsequent
immunohistochemical analysis. Baseline LV ejection fraction (EF) did not differ between
control and transplanted sheep (59.4 ± 8.1 % and 56.1 ± 10.6 %, mean ± SEM, respec-
tively). Two months later, LVEF was significantly higher in the transplanted group (72.6 ±
3.4 % vs 50.4 ± 3.4 % in controls, p = 0.02). This improvement was primarily related to a
decrease in systolic volumes following myoblast transfer (11.1 ± 4.4 cm3 vs 30.8 ± 3.1
cm3 in controls, p = 0.07) whereas diastolic volumes did not differ between the 2 groups.
These data suggest the functional efficacy of the transvenous coronary sinus technique
as a less invasive means of cell delivery to infarcted myocardium.
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1059-22 Cardiomyogenic Stem Cells in Human Bone Marrow
Winston Shim, Philip Wong, Jack Tan, Terrance Chua, Te Chih Liu, Winn Aye, Eugene 
Sim, National Heart Centre, Singapore, Singapore, National University Hospital, 
Singapore, Singapore
Introduction: Rodent bone marrow mesenchymal stem cells have been reported to
transdifferentiate into cardiomyogenic cells. However, there is little evidence to support
the existent of cardiomyogenic progenitors in human bone marrow.
Methods: Sternum bone marrow cells from 15 patients undergoing coronary artery
bypass surgery were enriched for mesenchymal stem cells by negative immuno-selection
against CD3, CD14, CD19, CD38, CD66b and GlyA markers. The enriched cells were
separated in Ficoll gradient and cultured with DMEM until fibroblastic colonies were
formed. The cells were expanded in differentiation medium with specially selected serum
and plated into tissue culture dishes at 104cells/cm2. After 5 days, the cells were stained
with antibodies against alpha smooth muscle actin (SMA), CD44, CD45, CD90, CD105/
SH2, CD106 and CD117 to confirm the identity of mesenchymal stem cells. Antibodies
against cardiac troponin I, cardiac troponin T, alpha/beta cardiac myosin heavy chain (α/
β MHC), sarcomeric tropomyosin, alpha-actinin, alpha-actin, titin and sarcoplasmic or
endoplasmic reticulum calcium ATPase 2 (SERCA2) were used to detect the presence of
cardiomyogenic cells.
Results: Immunohistochemical analyses revealed that about 1% of the cells in the colo-
nies were positive for troponin I in the unpassaged cultures. Approximately 80-90% of the
cells were stained positive for troponin I, α/β MHC, titin, tropomyosin, alpha-actinin,
alpha-actin, SERCA2 but negative for troponin T after 1 to 3 passages in differentiation
medium. Some nascent myofibrillar structures were observed in the cells. These myo-
genic cells also stained positive for SMA, CD44, CD90, CD105/SH2 and CD106 but neg-
ative for both CD45 and CD117.
Conclusion: Human adult bone marrow possesses a subpopulation of mesenchymal
stem cells with cardiomyogenic lineage that are expandable with a specific culture condi-
tion. This holds great promise for their use in cellular therapy to repair damaged myocar-
dium.
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1059-23 Cell Location May Be a Primary Determinant of Safety 
After Myoblast Transplantation Into the Infarcted Heart
Ahmed M. Soliman, Mitchell W. Krucoff, Suzanne Crater, Yoshihisa Morimoto, Doris A. 
Taylor, Duke University Medical Center, Durham, NC
Introduction :Arrhythmic complications associated with transplanting autologous myo-
blasts into infarcted myocardium can be fatal. The creation of an animal model to identify
the vulnerability of the myocardium to this phenomenon might assist in identifying factors
that contribute to these events. We hypothesize that cell location may be a primary factor
in the production of arrhythmias.
Methods: Fourteen days after LAD ligation, 1e8 myoblasts were injected into the center
(n=3; sham,n=1) or border zone (n=6; sham,n=2) of infarcted LV. A total of 1415 hrs con-
tinuous Holter monitoring was performed in 24 hr blocks at BASELINE (prior to injury)
(250 hrs), POST MI (288 hrs) and at 3 day intervals after therapy (877 hrs) until death or
30 day endpoint.
Results: BASELINE Holters showed occasional atrial and ventricular dysrhythmia includ-
ing premature atrial complexes. POST-MI animals showed new PVCs, couplets, and in 1
animal, sustained monomorphic V-tach. Hyperacute S-T elevations were seen in one ani-
mal POST MI and in one post sham injection. New dysrhythmias were not observed in
the other sham injections . After border zone injection of myoblasts, one or more of the
following were documented over serial recordings in each animal: more frequent and
polymorphic PVCs, faster and more aggressive couplets, triplets, more prolonged post-
PAC pauses, and bradycardic death, with a tendency for dysrhythmias to appear 6-9
days after cell injection. After cell injection into the center of the scar arrhythmias were
less-frequent and less-aggressive.
Conclusion:1. In rabbits, conduction abnormalities and supraventricular arrhythmias exist
at baseline 2. Post-MI; new dysrhythmias, especially monomorphic PVCs are commonly
observed. 3. Myoblast injection into the border zone of an infarct appears to lead to more
erratic and aggressive ventricular ectopy, conduction recovery delay and lethal bradycar-
dia compared to central scar injection. This rabbit model suggests location of cells
injected into myocardial scar may play a role in subsequent electrical vulnerability.
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1059-24 Physical Activity Attenuates the Risk of Stroke in 
Middle-Age Men With Left Ventricular Hypertrophy: 40-
Year Follow-Up (1961-2001) of the Corfu Cohort (Seven 
Countries Study)
Demosthenes B. Panagiotakos, Christos Pitsavos, Christina Chrysohoou, Alessandro 
Menotti, John Skoumas, Christodoulos Stefanadis, A' Cardiology Clinic, Athens, Greece
Background. We investigated the interaction between physical activity and left ventricular
hypertrophy (LVH) on stroke mortality, based on 40 years follow-up of the Corfu cohort
(Seven Countries Study). Methods. The population studied consisted of 529 rural men
(40 – 59 years old) enrolled at 1961. LVH was electrographically confirmed. Activity levels
were assessed by self-reports of habitual, occupational and leisure time physical activi-
ties. Cox proportional hazards models were used to assess the investigated parameters.
Results.During the 40-year follow up, 461 (87%) died, 74 (16%) of these deaths were due
to stroke. LVH was present in 40 individuals. Three hundred and sixty-two (68%) men
were defined as physically active. High fitness (>4 Kcal/min) was associated with 35%
lower risk of stroke (hazard ratio = 0.65, p<0.05), while the presence of LVH increased
the risk 5-fold (hazard ratio = 5.24, p<0.001). Multivariate analysis controlling for several
potential confounders revealed that increased fitness (>7 Kcal/min), attenuated the risk
of stroke by 24% (hazard ratio = 0.76, p = 0.008) in those with LVH. Conclusion. LVH is a
dominant characteristic of stroke mortality. Increased physical activity levels are associ-
ated with significantly lower stroke mortality in men with and without LVH.
Effect of Catecholamines on DFT
Group Routine DFT Experimental DFT p-value
BBL + Norepi (n=10) 9.5 ± 4.4 7.5 ± 3.5 0.037
No BBL + Norepi (n=6) 10.0 ± 3.2 7.5 ± 4.2 0.076
BBL + Epi (n=10) 8.0 ± 2.6 6.5 ± 2.4 0.081
No BBL + Epi (n=7) 10.4 ± 4.8 12.4 ± 7.0 0.296
Placebo (n=17) 9.4 ± 3.5 8.5 ± 3.9 0.332
